Drug Shortage Report for TEVA-PROPOFOL
| Report ID | 111871 |
| Drug Identification Number | 02437961 |
| Brand name | TEVA-PROPOFOL |
| Common or Proper name | PROPOFOL 10MG/ML INJ |
| Company Name | TEVA CANADA LIMITED |
| Market Status | DORMANT |
| Active Ingredient(s) | PROPOFOL |
| Strength(s) | 10MG |
| Dosage form(s) | EMULSION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 20, 50, & 100ml vial |
| ATC code | N01AX |
| ATC description | ANESTHETICS, GENERAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-04-08 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-05-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-05-14 | French | Compare |
| v5 | 2020-05-14 | English | Compare |
| v4 | 2020-05-08 | French | Compare |
| v3 | 2020-05-08 | English | Compare |
| v2 | 2020-04-10 | French | Compare |
| v1 | 2020-04-10 | English | Compare |
Showing 1 to 6 of 6